ICER Publishes Final Evidence Report on Digital Therapeutics for Opioid Use Disorder

ICER Publishes Evidence Report on Digital Therapeutics for Opioid Use Disorder The Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report and Report-at-a-Glance assessing the comparative clinical effectiveness and value of three digital health technologies (DHTs) that have been developed to treat opioid use disorder (OUD):

• reSET-O® (Pear Therapeutics), a 12-week prescription digital app, used in conjunction with buprenorphine and small rewards, aimed at increasing retention of patients receiving outpatient OUD treatment
• Connections (Chess Health), a digital app that combines communication with addiction experts and support groups, along with a 7-session program that teaches cognitive and behavioral skills, aimed at improving abstinence in patients with substance use disorders
• DynamiCare (DynamiCare Health), a digital app that includes 36 classroom-based training modules, monitoring for substance abstinence, and debit card rewards for negative drug tests and appointment attendance

“Medication-assisted treatment (MAT) saves lives and money, and new interventions should be developed, tested, and implemented that can augment the number of individuals who can access MAT, reduce stigma, and ensure that individuals receive care in a format that helps them achieve their goals,” said Steven D. Pearson, MD, MSc, ICER’s President. Read more here.